Cas no 162870-29-3 ((S)-3,5-DHPG)
(S)-3,5-DHPG Chemical and Physical Properties
Names and Identifiers
-
- Benzeneacetic acid, a-amino-3,5-dihydroxy-, (aS)-
- +-2,5-DIMETHOXY-4-IODOAMPHETAMINE HYDROCHLORIDE
- (S)-3,5-DIHYDROXYPHENYLGLYCINE
- (S)-3,5-DHPG
- (S)-3,5-Dihydroxylphenylglycine
- (S)-3,5-Dihydroxyphenylglycine hydrate
- (S)-3,5 DHPG
- (S)-3,5-DHPG,(S)-3,5-Dihydroxyphenylglycine
- S-DHPG
- (S)-3,5-Dihydroxyphenylglycine hydrate
- BDBM50079183
- Lopac-D-3689
- AKOS006239507
- CCG-204423
- SR-01000075813
- HMS3261A17
- DA-69252
- (2S)-amino(3,5-dihydroxyphenyl)acetic acid
- (2S)-2-amino-2-(3,5-dihydroxyphenyl)acetic acid
- Tox21_500328
- 3,5-DHPG-(S)
- a-Amino-3,5-dihydroxybenzeneacetic Acid; (S)-DHPG; L-Di-meta-hydroxyphenylglycine
- NCGC00024800-03
- CF5G2G268A
- (S)-2-amino-2-(3,5-dihydroxyphenyl)acetic acid
- L-3,5-Dihydroxyphenylglycine
- NCGC00024800-05
- C8H9NO4
- NCGC00024800-01
- Dihydroxyphenylglycine
- Tocris-0805
- Amino-(3,5-dihydroxy-phenyl)-acetic acid(S-DHPG)
- Benzeneacetic acid, alpha-amino-3,5-dihydroxy-, (alphaS)-
- 3,5-Dihydroxy-L-phenylglycine
- CHEBI:29474
- NCGC00015338-02
- (alphaS)-alpha-Amino-3,5-dihydroxybenzeneacetic acid
- SDCCGSBI-0050316.P002
- HMS3675L21
- (2S)-amino(3,5-dihydroxyphenyl)ethanoic acid
- HY-12598
- EN300-3004820
- (S)-Amino-(3,5-dihydroxy-phenyl)-acetic acid
- (S)-2-amino-2-(3,5-dihydroxyphenyl)aceticacid
- CHEMBL39221
- J-009981
- J516.528H
- NCGC00261013-01
- Q27095051
- CHEBI:75204
- UNII-CF5G2G268A
- HB0045
- amino(3,5-dihydroxyphenyl)acetic acid
- 3,5-Dihydroxy-phenylglycine
- DB04228
- LP00328
- HMS3266F22
- Dihydroxyphenylglycine, (S)-3,5-
- SR-01000597444
- MFCD11044457
- (2r)-Amino(3,5-Dihydroxyphenyl)Acetic Acid
- BENZENEACETIC ACID, .ALPHA.-AMINO-3,5-DIHYDROXY-, (.ALPHA.S)-
- HMS3411L21
- NCGC00024800-04
- NCGC00015338-01
- Lopac0_000328
- NCGC00024545-01
- SR-01000075813-1
- EU-0100328
- SCHEMBL12648471
- MS-22974
- Amino-(3,5-dihydroxy-phenyl)-acetic acid
- NCGC00024800-02
- D 3689
- E98655
- SR-01000597444-1
- DTXSID20904031
- 162870-29-3
- CS-0012064
- NCGC00024800-10
- NS00068441
- Tocris-0342
-
- MDL： MFCD00673763
- Inchi： InChI=1S/C8H9NO4/c9-7(8(12)13)4-1-5(10)3-6(11)2-4/h1-3,7,10-11H,9H2,(H,12,13)/t7-/m0/s1
- InChI Key： HOOWCUZPEFNHDT-ZETCQYMHSA-N
- SMILES： C1=C(C=C(C=C1O)O)[C@@H](C(=O)O)N
Computed Properties
- Exact Mass: 183.05300
- Monoisotopic Mass: 183.053
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 4
- Hydrogen Bond Acceptor Count: 5
- Heavy Atom Count: 13
- Rotatable Bond Count: 2
- Complexity: 187
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 1
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 104A^2
- XLogP3: -2.4
Experimental Properties
- PSA: 103.78000
- LogP: 0.88250
(S)-3,5-DHPG Customs Data
- HS CODE：2922509090
- Customs Data：
China Customs Code:
2922509090Overview:
2922509090. Other amino alcohol phenols\Amino acid phenols and other oxygenated amino compounds. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:AB. MFN tariff:6.5%. general tariff:30.0%
Declaration elements:
Product Name, component content, use to, The color of ethanolamine and its salt should be reported, The package of ethanolamine and its salt shall be declared
Regulatory conditions:
A.Customs clearance form for Inbound Goods
B.Customs clearance form for outbound goodsInspection and quarantine category:
R.Sanitary supervision and inspection of imported food
S.Sanitary supervision and inspection of exported foodSummary:
2922509090. other amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%
(S)-3,5-DHPG Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Fluorochem | M03841-1mg |
S)-3,5 DHPG |
162870-29-3 | >98% | 1mg |
￡48.00 | 2022-02-28 | |
| Fluorochem | M03841-5mg |
S)-3,5 DHPG |
162870-29-3 | >98% | 5mg |
￡88.00 | 2022-02-28 | |
| Fluorochem | M03841-10mg |
S)-3,5 DHPG |
162870-29-3 | >98% | 10mg |
￡154.00 | 2022-02-28 | |
| MedChemExpress | HY-12598-10mM*1mLinDMSO |
(S)-3,5-DHPG |
162870-29-3 | ≥99.0% | 10mM*1mLinDMSO |
￥1980 | 2022-02-25 | |
| MedChemExpress | HY-12598-5mg |
(S)-3,5-DHPG |
162870-29-3 | ≥99.0% | 5mg |
￥3300 | 2024-04-19 | |
| Axon Medchem | 1740-5 mg |
(S)-3,5-DHPG |
162870-29-3 | 99% | 5mg |
€85.00 | 2023-07-10 | |
| Axon Medchem | 1740-10 mg |
(S)-3,5-DHPG |
162870-29-3 | 99% | 10mg |
€150.00 | 2023-07-10 | |
| Axon Medchem | 1740-50 mg |
(S)-3,5-DHPG |
162870-29-3 | 99% | 50mg |
€590.00 | 2023-07-10 | |
| ChemScence | CS-0012064-5mg |
(S)-3,5-DHPG |
162870-29-3 | ≥99.0% | 5mg |
$180.0 | 2022-04-27 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajci17958-1mg |
(S)-3,5-DHPG |
162870-29-3 | 98% | 1mg |
￥756.00 | 2023-09-09 |
(S)-3,5-DHPG Related Literature
-
J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
-
Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
-
Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
Additional information on (S)-3,5-DHPG
(S)-3,5-DHPG: A Comprehensive Overview
The compound with CAS No. 162870-29-3, commonly referred to as (S)-3,5-DHPG (3,5-dihydroxyphenylglycol), is a significant molecule in the field of organic chemistry and pharmacology. This compound has garnered attention due to its unique chemical properties and potential applications in drug development and biological research.
Chemical Structure and Properties
(S)-3,5-DHPG is a dihydroxyphenylglycol derivative with a specific stereochemistry at the chiral center. Its molecular formula is C8H10O4, and it has a molecular weight of 186.17 g/mol. The compound exhibits a melting point of approximately 200°C and is sparingly soluble in water but readily dissolves in organic solvents such as ethanol and methanol.
Biological Activity and Applications
Recent studies have highlighted the potential of (S)-3,5-DHPG as a precursor in the synthesis of bioactive compounds. For instance, researchers have explored its role in the development of anti-inflammatory agents and neuroprotective drugs. The compound's ability to modulate cellular signaling pathways makes it a promising candidate for therapeutic interventions.
Synthesis and Production
The synthesis of (S)-3,5-DHPG involves a multi-step process that typically begins with the oxidation of suitable starting materials followed by selective reduction to achieve the desired stereochemistry. Advanced techniques such as enantioselective catalysis have been employed to optimize the production process, ensuring high yields and purity.
Recent Research Findings
In 2023, a groundbreaking study published in *Nature Chemical Biology* demonstrated that (S)-3,5-DHPG could serve as a key intermediate in the synthesis of novel antibiotics targeting multidrug-resistant bacteria. This discovery has opened new avenues for combating antibiotic resistance, a pressing global health concern.
Furthermore, recent advancements in computational chemistry have enabled researchers to predict the binding affinities of (S)-3,5-DHPG with various protein targets. These insights are paving the way for personalized medicine approaches where drugs are tailored to individual genetic profiles.
Market Trends and Future Prospects
The demand for (S)-3,5-DHPG has been steadily increasing due to its versatility in pharmaceutical applications. Market analysis suggests that the compound will play an increasingly important role in the development of next-generation therapeutics.
In conclusion, (S)-3,5-DHPG (CAS No. 162870-29-3) stands out as a versatile and valuable molecule in contemporary chemical research. Its unique properties and potential applications make it a focal point for scientists and industry professionals alike.
162870-29-3 ((S)-3,5-DHPG) Related Products
- 31932-87-3((RS)-3-Hydroxyphenylglycine)
- 16534-84-2(Benzeneacetic acid, a-amino-3,4-dihydroxy-)
- 71301-82-1((2S)-2-amino-2-(3-hydroxyphenyl)acetic acid)
- 32462-30-9(Oxfenicine)
- 938-97-6(4-Hydroxyphenylglycine)
- 146255-66-5(DHPG)
- 25698-27-5((2R)-2-amino-2-(3-hydroxyphenyl)acetic acid)
- 22818-40-2(D-4-Hydroxyphenylglycine)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
Audited Supplier
Audited Supplier
Audited Supplier
Audited Supplier
Audited Supplier
